- Home
- CTNM vs BNTC Comparison
CTNM vs BNTC Comparison
Compare CTNM & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- BNTC
- Stock Information
- Founded
- CTNM 2009
- BNTC 1995
- Country
- CTNM United States
- BNTC United States
- Employees
- CTNM N/A
- BNTC N/A
- Industry
- CTNM
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- CTNM
- BNTC Health Care
- Exchange
- CTNM Nasdaq
- BNTC Nasdaq
- Market Cap
- CTNM 328.1M
- BNTC 365.1M
- IPO Year
- CTNM 2024
- BNTC N/A
- Fundamental
- Price
- CTNM $11.01
- BNTC $16.36
- Analyst Decision
- CTNM Strong Buy
- BNTC Strong Buy
- Analyst Count
- CTNM 5
- BNTC 5
- Target Price
- CTNM $22.20
- BNTC $24.80
- AVG Volume (30 Days)
- CTNM 92.7K
- BNTC 68.9K
- Earning Date
- CTNM 10-30-2025
- BNTC 11-12-2025
- Dividend Yield
- CTNM N/A
- BNTC N/A
- EPS Growth
- CTNM N/A
- BNTC N/A
- EPS
- CTNM N/A
- BNTC N/A
- Revenue
- CTNM N/A
- BNTC N/A
- Revenue This Year
- CTNM N/A
- BNTC N/A
- Revenue Next Year
- CTNM N/A
- BNTC N/A
- P/E Ratio
- CTNM N/A
- BNTC N/A
- Revenue Growth
- CTNM N/A
- BNTC N/A
- 52 Week Low
- CTNM $3.35
- BNTC $9.10
- 52 Week High
- CTNM $20.24
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- CTNM 48.88
- BNTC 64.67
- Support Level
- CTNM $10.77
- BNTC $15.20
- Resistance Level
- CTNM $11.34
- BNTC $16.67
- Average True Range (ATR)
- CTNM 0.68
- BNTC 0.86
- MACD
- CTNM -0.15
- BNTC 0.01
- Stochastic Oscillator
- CTNM 31.37
- BNTC 81.65
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.